Tessie is a drug owned by ORION CORP. It is protected by 2 US drug patents filed from 2033 to 2038. All patents are active. Details of Tessie’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US9249127 | 28 Mar, 2033 | Active |
Exclusivity Information
Tessie holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2031. Details of Tessie's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | May 06, 2031 |
About Tessie
Tessie is a drug
owned by ORION CORP.
Tessie uses
Tasipimidine as the active
ingredient.
Active Ingredient:
Tessie uses
Tasipimidine as the active ingredient.
Check out other Drugs and Companies using
Tasipimidine ingredient.